STM32 JW01

jw001JW Pharmaceutical has presented positive preclinical data on JW0061, a novel Wnt-targeted hair loss treatment, at the U.S. Society of Investative Dermatology meeting. What are Wnt-Targeted Hair LossExplore jw001's Lynk Profile to discover products, social media accounts, and know more about jw001. Create Instant Mobile Webpage to sell your knowledge. Chat, Video Calls, Events, Dital Product. Share it across social media. Home